FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

834221000168109: aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet (medicinal product unit of use)

Status: current, Defined. Date: 31-Oct 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1693691000168111 aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1693701000168111 aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet Is a aspirin + codeine true Inferred relationship Some
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet Is a aspirin 300 mg dispersible tablet true Inferred relationship Some
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet has manufactured dose form dispersible tablet true Inferred relationship Some
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet has unit of use tablet true Inferred relationship Some 1166844230
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet has intended active ingredient codeine true Inferred relationship Some 1166844229
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet has Australian BoSS codeine phosphate hemihydrate true Inferred relationship Some 1166844229
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet has Australian BoSS aspirin true Inferred relationship Some 518637418
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet has intended active ingredient aspirin true Inferred relationship Some 518637418
Inbound Relationships Type Active Source Characteristic Refinability Group
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 40 has MPUU True aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet Inferred relationship Some 1
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 20 has MPUU True aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet Inferred relationship Some 1
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 50 has MPUU True aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet Inferred relationship Some 1
aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 100 has MPUU True aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet Inferred relationship Some 1
Aspalgin dispersible tablet Is a True aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet Inferred relationship Some

Reference Sets

Tasmania reportable Schedule 4 medications reference set

Victoria reportable Schedule 4 medications reference set

South Australia reportable Schedule 4 medications reference set

Queensland Health QScript Schedule 4 monitored medicines reference set

New South Wales Reportable Schedule 4 medications reference set

Northern Territory Reportable Schedule 4 medications reference set

ACT Reportable Schedule 4 medications reference set

Western Australia Health Schedule 4 restricted medicines for public hospitals reference set

Medicinal product unit of use reference set

Back to Start